Clinical Trials Directory

Trials / Completed

CompletedNCT06174961

The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin

The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin: A Randomized, Controlled, Cross-over Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Kristian Karstoft · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The aim of this project is to assess the influence of exercise on pharmacokinetics (PK) and pharmacodynamics (PD) of a single dose of subcutaneously (sc) administered unfractionated heparin (UFH). It is hypothesized that exercise will increase the systemic exposure (PK) and therefore the clinical effects (PD) of the sc administered UFH. To assess this, healthy male volunteers will be included in a controlled, randomized, crossover study, where they, on four separate days, will have UFH injected sc in the thigh, followed by different exercise interventions (one per experimental day). Blood sampling, with the aim of assessing PK and PD will be performed during the following hours.

Conditions

Interventions

TypeNameDescription
DRUGUnfractionated heparin15,000 units of unfractionated heparin administered in the thigh
BEHAVIORALDouble-legged cycle ergometer exerciseOne hour of double-leg cycle ergometer exercise
BEHAVIORALSingle-legged cycle ergometer exercise, with unfractionated heparin injection in the exercising legOne hour of single-leg cycle ergometer exercise, after unfractionated heparin injection in the ipsilateral leg
BEHAVIORALSingle-legged cycle ergometer exercise, with unfractionated heparin injection in the non-exercising legOne hour of single-leg cycle ergometer exercise, after unfractionated heparin injection in the ipsilateral leg
BEHAVIORALNo exerciseNo exercise

Timeline

Start date
2023-09-22
Primary completion
2024-02-13
Completion
2024-05-01
First posted
2023-12-18
Last updated
2024-06-26

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT06174961. Inclusion in this directory is not an endorsement.